Grifols SA (GRFS)
7.50
-0.02
(-0.27%)
USD |
NASDAQ |
Oct 07, 16:00
7.38
-0.12
(-1.60%)
After-Hours: 06:42
Grifols Price : 7.50 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 7.48 | 7.56 | 7.44 | 7.50 | 260701.0 |
| Oct 06, 2026 | 7.53 | 7.565 | 7.415 | 7.52 | 326101.0 |
| Oct 05, 2026 | 7.31 | 7.54 | 7.29 | 7.41 | 492766.0 |
| Oct 02, 2026 | 7.30 | 7.36 | 7.24 | 7.31 | 390350.0 |
| Oct 01, 2026 | 7.29 | 7.33 | 7.195 | 7.30 | 623126.0 |
| Sep 30, 2026 | 7.35 | 7.38 | 7.30 | 7.31 | 772968.0 |
| Sep 29, 2026 | 7.40 | 7.415 | 7.235 | 7.295 | 485004.0 |
| Sep 28, 2026 | 7.35 | 7.47 | 7.345 | 7.41 | 597124.0 |
| Sep 25, 2026 | 7.36 | 7.389 | 7.294 | 7.35 | 507229.0 |
| Sep 24, 2026 | 7.17 | 7.28 | 7.15 | 7.20 | 536150.0 |
| Sep 23, 2026 | 7.33 | 7.38 | 7.19 | 7.195 | 4.065M |
| Sep 22, 2026 | 7.41 | 7.45 | 7.39 | 7.44 | 600101.0 |
| Sep 21, 2026 | 7.34 | 7.39 | 7.325 | 7.36 | 356734.0 |
| Sep 18, 2026 | 7.37 | 7.41 | 7.29 | 7.31 | 367746.0 |
| Sep 17, 2026 | 7.40 | 7.435 | 7.38 | 7.40 | 244639.0 |
| Sep 16, 2026 | 7.41 | 7.41 | 7.34 | 7.40 | 471633.0 |
| Sep 15, 2026 | 7.40 | 7.469 | 7.34 | 7.36 | 590627.0 |
| Sep 14, 2026 | 7.59 | 7.60 | 7.46 | 7.48 | 294649.0 |
| Sep 11, 2026 | 7.67 | 7.72 | 7.55 | 7.55 | 513348.0 |
| Sep 10, 2026 | 7.73 | 7.74 | 7.64 | 7.65 | 302562.0 |
| Sep 09, 2026 | 7.77 | 7.89 | 7.71 | 7.82 | 703342.0 |
| Sep 08, 2026 | 7.78 | 7.83 | 7.74 | 7.75 | 298391.0 |
| Sep 04, 2026 | 7.82 | 7.84 | 7.77 | 7.80 | 157911.0 |
| Sep 03, 2026 | 7.90 | 7.99 | 7.81 | 7.88 | 513399.0 |
| Sep 02, 2026 | 7.71 | 7.848 | 7.70 | 7.83 | 261703.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| argenx SE | 928.44 |
| Evaxion AS | 3.16 |
| Akari Therapeutics Plc | 8.625 |
| Pharma Mar SA | 94.60 |
| Oryzon Genomics SA | 3.098 |
Price Related Metrics
| PE Ratio | 9.679 |
| PS Ratio | 0.5896 |
| PEG Ratio | 0.1569 |
| Price to Book Value | 0.805 |
| Price to Free Cash Flow | 6.907 |
| Earnings Yield | 10.33% |
| Market Cap | 1.937B |
| PEGY Ratio | 0.1479 |
| Operating PE Ratio | 3.633 |
| Normalized PE Ratio | 9.679 |